Phase 3 Readout

SMNR: Phase 3 Topline: Corticosteroid Lumbar Epidural Analgesia for Radicular Pain (C.L.E.A.R) 2 - A Randomized, Double-bli

Name: Phase 3 Topline: Corticosteroid Lumbar Epidural Analgesia for Radicular Pain (C.L.E.A.R) 2 - A Randomized, Double-bli
Start: 2029-01-01
End: 2029-01-01

January 1, 2029 · sp-102. BioSniper AI can trace the company-impact path without requiring you to write the research question.

Event date: January 1, 2029
Company: SEMNUR PHARMACEUTICALS, INC. (SMNR)
Drug: sp-102

BioSniper AIPage evidence connected

Prepared research question

What could this event change, and which evidence should be watched next?

Run cited research

Traceable citations · Unknowns marked

Phase 3 Readout~month

Phase 3 Topline: Corticosteroid Lumbar Epidural Analgesia for Radicular Pain (C.L.E.A.R) 2 - A Randomized, Double-bli

January 1, 2029

SMNR overview →

Company: SEMNUR PHARMACEUTICALS, INC. (SMNR)
Drug: sp-102
Indication: Lumbosacral Radicular Pain